View our archive of investor presentations, annual and interim reports from 4D pharma plc (AIM: DDDD)

Developing Science, Delivering Therapies

Management presentation, March 2020


Chardan's 2nd Annual Microbiome Medicine Summit, 16 March 2020

CEO Duncan Peyton and CSO Alex Stevenson provide an update on clinical progress in oncology, and timelines and catalysts for 2020


View RNS announcements

Subscribe to RNS email alerts


Date 2019 Sep 30
Title Interim results for the period ended 30 June 2019
Document (629KB)
Link
Date 2019 May 28
Title Annual report for the year ended 31 December 2018
Document (4,255KB)
Link
Date 2018 Sep 28
Title Interim results for the period ended 30 June 2018
Document (269KB)
Link visit
Date 2018 Apr 25
Title Annual report for the year ended 31 December 2017
Document (1,369KB)
Link
Date 2017 Sep 27
Title Interim results for the period ended 30 June 2017
Document (2,820KB)
Link
Date 2017 May 02
Title Annual report for the year ended 31 December 2016
Document (3,262KB)
Link
Date 2016 Sep 30
Title Interim results for the period ended 30 June 2016
Document
Link visit
Date 2016 May 06
Title Annual report for the year ended 31 December 2015
Document (771KB)
Link
Date 2015 Sep 29
Title Interim results for the period ended 30 June 2015
Document (429KB)
Link
Date 2015 May 06
Title Annual Report for the year ended 31 December 2014
Document (659KB)
Link
Date 2014 Sep 23
Title Interim results for the period ended 30 June 2014
Document
Link visit

For any enquiries please contact ir@4dpharmaplc.com

BACK TO TOP